¤j¨§¤¤§ÜÀç¾i¦]¤l¤§±´°Q¤Î¨ä¹ï¹}¾i®ÄªG¤§¼vÅT
¡@
¤@¡B«e ¨¥ »·¦Û¦è¤¸«e1000¦~¡A¤j¨§(soybean)¤w¬°»·ªF¦a°Ï¡A¯S§O¬O¤¤°ê¤Î¤é¥»¤§¹ª«²Õ¦¨¡F¦ý¦b¦è¤è°ê®a¤j¶q®â´ÓªÌ¡A¤D¬O¤Q¤E¥@¬ö¥½´Á¡A§@¬°²i½Õ¥Îªo(cooking oil)¨Ó·½¡C1917¦~¡AOsborne and Mendel¸ÕÅç¬ã¨s«á¶}©l¡A¦h¦~¨Ó¸g¥[¼ö³B²z¤§¤j¨§²Ë(heattreated soybean meal)¤w¼sªx¥Î¬°°Êª«¤§³J¥Õ½è¨Ó·½¡C¥H¥Í¤j¨§©Î¥[¼ö¤£·í¤§¤j¨§²ËÁý¹}¥J¯b¡A·|°§C¹}®Æ±Ä¹¶q¡B°§C¹ï¤é³¤¤´á¡BºÒ¤ô¤Æ¦Xª«¡B¯×½è¤§®ø¤Æ»P§l¦¬¡F¨Ã°§C¤w§l¦¬¤§´áªº»W¿n¡A´£°ªÅé¯×ªÕ¤§¤À¸Ñ§@¥Î¡A²×¦Ó¨î¹}®Æ§Q¥Î®Ä²v¡C¦Ó¹ï¹«¡BÂúÃZ¤ÎÂû°¦¦Ó¨¥¡A¥ç¨ã¯ØŦ¸~¤j¡B¯ØŦ»Ã¯À¤Àªc¼W¥[¤§¤£¨}¼vÅT¡C
¤wª¾¤j¨§§Ü줧§í¨î¥Íªø¡B¤zÂZ¸z¹D¤Î²Õ´¥NÁ¡A«Y¦]§ÜÀç¾i¦]¤l(anti-nutritional factors)¤§¦s¦b©ÒP¡F¥]¬Atrypsin inhibitors¡Blectin¡Bglycinin¤Îconglycininµ¥¡CPontit et al. (1987)§Q¥ÎªÎ¨|½Þ°¦¤ñ¸û¤j¨§²Ë»P¥Í¤j¨§¤§¹}¾i®ÄªGµo²{¡AÀHµÛ¥Í¤j¨§¥Î¶q¤§¼W¥[¡A½T¦³°§C¥Íªø¡A¹}®Æ®Ä²v»P±OÅé«~½è¤§¼vÅT¡F¦ÓCook et al. (1988)¥H§C¶qKunitz trypsin inhibitorÁý¤©¥Íªø½Þ¤ÎªÎ¨|½Þ¡A¦A¦¸ÃÒ¹ê¥Í¤j¨§¤¤©Ò§t¤§§í¨î¦]¤l½T¦³§í¨î¥Íªøªº®ÄªG¡C
¤G¡B¤j¨§¤¤§ÜÀç¾i¦]¤lªº±´°Q
¥J¯bÁý¤©§t¤j¨§©Î¥[¼ö¤£·í¤§¤j¨§²Ë¤é³¡A¨ä¥Íªø©Ê¯à»·¸û§t¦×¯»©Î¨Å³J¥ÕªÌ¬°®t(Grant¡A1989)¡Cªí¤@¬°¹«Áý¤©§t¦UºØ³J¥Õ½è¨Ó·½©ÎµL³J¥Õ½è¤é³¤§¥Íªø±¡§Î¤ñ¸û¡C²b³J¥Õ½è§Q¥Î(NPU¡Anet protein Utilization)¡A¹}®Æ±Ä¹¶q¤Î¼W«¥H¥Õ³J¥Õ(egg albumin)¬°³Ì¨Î¡A¨ä¦¸¬°¸g¥[¼ö³B²z¤§¤j¨§²Ë¡A¾lªÌ¨Ì§Ç¬°¥Í¤j¨§¸É¥Rª«¡B¥Í¤j¨§¡FµL³J¥Õ½è¤é³²Õ³Ì®t¡A©ó10¤é¸ÕÅç´Á¶¡Áö¦³±Ä¹(191§J)¡A¦ý¤wµL²b³J¥Õ§Q¥Î¡A¥BÅé««ùÄò¥¢«¤¤(ªí¤@)¡C§@ªÌ«ü¥X¡A¥Í¤j¨§»P¥[¼ö³B²z¹L¤§¤j¨§²Ë¶¡¹ï¥Íªø©Ê¯à¦³¦p¦¹¤j¤§®t²§¡A¥D¦]©ó¤j¨§¤¤©Ò§t½Ñ¦h§ÜÀç¾i¦]¤l(anti-nutritional factors)¤§¬G¡F¨Ò¦ptrypsin inhibitors¤Îlectin (Liener, 1981)¡C³\¦h³ø§i«ü¥X¡A§ÜÀç¾i¦]¤l¤§¦s¦b¡A·|°§C¹}®Æ±Ä¹¶q(Liener, 1981)¡A°§C¤é³¤¤´á(Nitsan and Liener, 1976)¡BºÒ¤ô¤Æ¦Xª«(Santidrian et al., 1973)¡B¯×½è(Sklan et al., 1973)¤§®ø¤Æ»P§l¦¬¡F°§C¤w§l¦¬¤§´áªº»W¿n(Grant et al., 1986)¡B´£°ªÅé¯×¤§¤À¸Ñ§@¥Î(Grant et al., 1988)¡A¦]¦Ó¨î¹}®Æ§Q¥Î®Ä²v¡A°§C¥Íªø©Ê¯à¡C¥Í¤j¨§¥ç·|»¤µo¯ØŦ»Ã¯À(Lyman and Lepovsky, 1957¡FGertler and Nitsan, 1970)¤ÎÁx¥Ä(Sklan et al., 1973¡FRoy and Schneeman, 1981)¹L«×¤Àªc¡A¨Ï¦¹¨Ç§@¥Î¤é³Àç¾i¤À¤§¦¨¥÷³à¥¢¡A¤Þ°_®ø¤Æ¡B§l¦¬¤£¨}¡CCoates et al. (1970)«ü¥X¡A¥Í¤j¨§¤¤©Ò§t¤§¥Íªø§í¨î¦]¤l·|³y¦¨¸z¤ºµß¬Û¤§ÅܤơF¥¿½T¾÷¨îÁö¥¼©ú½T¡A¦ý¥i¯à»P¥Í¤j¨§¤§Áý¤©¡A·|ªýê¬Y¨ÇG¸z¹D¤¤²Óµß¤§¼W´Þ¡A¦]¦Ó§ïÅܸz¹D²Óµß¶¡¤§¥¿Å¡A¨Ã¥B³y¦¨§ó¦h¯fì©Ê«~¨t¤§²Óµß©ó¸z¤¤¼W´Þ¦³Ãö(Lhuillery et al., 1982)¡C
ªí¤@ ¤j ¨§ ¹ï ¥® ¯b ¸V ¤§ ¥Í ªø §í ¨î §@ ¥Î
¡@ | ¥Í ¤j ¨§ | ¸g ¥[ ¼ö ³B ²z ¤§ ¤j ¨§ ²Ë |
¹«¤Î¤j¥Õ¹« ¥Ð¹«¤Î¤ÑªÇ¹« Âû°¦¤ÎÂúÃZ óγ½¤Î Ã}¤û ½Þ ¯Ì¦Ï µU ¤HÃþ |
¡Ï¡Ï ¡Ï¡Ï ¡Ï¡Ï ¡Ï¡Ï ¡Ï¡Ï ¡Ï¡Ï ¡Ï¡Ï ¡H ¡H |
¡Ð ¡Ð ¡Ð ¡Ð ¡Ï ¡Ï ¡Ï ¡Ð ¡Ð |
¥Í¤j¨§¹ï¦hºØ¥®¯b¤§¥Íªø§í¨î§@¥Î·¥¬°±j¯P(ªí¤@)¡A¥]¬A¹«¡B¤j¥Õ¹«¡B¥Ð¹«¡B¤ÑªÇ¹«¡BÂû°¦¡BÂúÃZ¡Bóγ½¡BÃU³½¡BÃ}¤û¡B½Þ°¦»P¥J¦Ïµ¥¡A¦Ó¹ïµU¤l»P¥®¨àªº¼vÅT«h¥¼½Tª¾¡C¸g¥[¼ö³B²z¹L¤§¤j¨§²Ë¤´¹ïÃ}¤û¡B½Þ°¦»P¥J¦Ï¨ã¦³ÅãµÛ¤§¥Íªø§í¨î§@¥Î¡AÅã¥Ü¥[¼ö³B²z¤§¤j¨§²Ë¤´¦³§ÜÀç¾i¦]¤l¤§¦s¦b¡CBarrat et al.(1978)¡AKilshaw and Si-ssons(1970)«ü¥X¡A¥Í¤j¨§¹ïÃ}¤û¤§¥Íªø§í¨î§@¥Î¡A¤D¦]Áý¹}¥Í¤j¨§«á¤ÞµoIgE¡AIgGµ¥§ÜÅéµo¥Í¤j¨§©Ò§tªº¦¨¥÷¡Ðglycinin¡Bconglycinin²£¥Í¹L±Ó©Ê¤ÏÀ³¡F³y¦¨¤p¸z¤W¥Ö²ÓM±Y¸Ñ¡B¤W¥Ö²ÓM§e²{¤£³W«h¤Æ¡A¸zµ³¤òÅܲʡBÅܵu¡A§õ°ö©ø¤ó¸¢ºÛ(Lieberkuhn crypts)¥[²`µ¥¸z¹D¶Ë®`¡FP¨Ï®ø¤Æ²G³z¹L¤p¸zµo¥ÍÅܤơAÀç¾i¤À¤§²b§l¦¬¦]¦Ó°§C¡C¥Í¤j¨§©Î¸g¥[¼ö³B²z¹L¤§¤j¨§²ËÁý¤©¥J½Þ³y¦¨¤§¬Û¦P¼vÅT¡A¥iÂǥѨŻs«~¤§¨ú¥N¦Ó®ø¥¢¡FGrant(1989)«ü¥X¡A¤j¨§²Ë¤¤©Ò§t¤§¤j¨§§Üì(soybean antigens»¤µo¥J½Þ¤§ce-ll-mediated delayed hypersensitivity reactions¡A¦Ó¨Ï¥Íªø©Ê¯à°§C¡CMiller et al.(1984a¡Bb)¤]«ü¥X¡AÂ÷¨Å«á¤§¹L±Ó©Ê¤ÏÀ³(post-weaning hypersensitivity reactions)»P¥Íªø°±º¢¡A¥i©ó¥J½ÞÂ÷¨Å«e±µ¨ü¤Ö¶q¸g¥[¼ö³B²z¹L¤§¤j¨§²Ë¡A¨Ï§K¬Ì¨t²Î¼W¥[@¨ü©Ê¡A´î¤ÖÂ÷¨Åªº¸gÀÙ·l¥¢¦ÓÀò±o§ïµ½¡C ¤é³¤¤§t¦³¥Í¤j¨§¡A¥ç¹ï¥J¯b¤§¯ØŦ¤j¤p¤Î¯ØŦ»Ã¯À¤Àªc¦³¼vÅT¡C·íÄṥͤj¨§¤é³«á¡A·|³y¦¨¹«¡B¤j¥Õ¹«¡B¥Ð¹«¡B¤ÑªÇ¹«¡BÂû°¦¤ÎÂúÃZ¤§¯ØŦ¸~¤j»P¯ØŦ»Ã¯À¤Àªc¼W¥[(ªí¤G¡AGrant, 1989)¡FRoy and Schnecman (1981)¡BRackis et al. (1979)«ü¥X¡A¥Í¤j¨§¤é³¼W¥[¯ØŦ¤¤trypsin¡Bchymotrypsin¡Bamylase¤Îesterase¤§¤Àªc¡A¦]¦Ó°§C¯ØŦ¤¤trypsin¡Bohymotrypsin¤§¤ô·Ç¡A¾ÉP¯ØŦ¤¤»Ã¯À¦X¦¨³t²v¼W¥[¡FY«ùÄòÁý¹}¡A«h·|¦]²ÓM¤§¼W¤j»P¼W¥Í³y¦¨¯ØŦ¸~¤j¡C¹ï¥J½Þ¦Ó¨¥¡A¥Í¤j¨§¤é³·|§ïÅܯØŦ¥\¯à¡A¦ý¹ï¤j¤p«hµL¼vÅT¡A±©¨ã¦³¤UzÅܤơG·íº¦¸±µ¨ü¥Í¤j¨§¤é³®É¡A¯Ø²G»P¯Ø³J¥ÕúA¤§¤Àªc¼W¥[¡F«ùÄòÁý¹}¤U¡A·|ºû«ù¼Æ¤Ñªº¤W¤É²{¶H¡AÀH«á«hµo¥Í¯ØŦ»Ã¯À¤Àªc¤£¨¬¡A¯ØŦ¤¤trypsin¡Bchymotrypsin¶q¤j¤j¦a°§C(Yen et al., 1977)¡C¦]¦¹¡A¥H¥Í¤j¨§Áý¤©¥J½Þ¡AÄY«¯}Ãa¯ØŦ»Ã¯À¤§¦X¦¨¤Î©Î¤zÂZ¨ä¹Lµ{¡A²×¦Ó¨î»Ã¯À¤§¤Àªc¡A°§C°Êª«®ø¤Æ¤é³Àç¾i¤À¤§®Ä²v¡C ªí¤G §t¥Í¤j¨§¤é³¹ï¥J¯b¸V¯ØŦ¤§¼vÅT¡Ï¡Ï¡A±j¯P§í¨î¥Íªø¡F¡Ï¡A³y¦¨ÅãµÛ©Ê¥Íªø§í¨î§@¥Î¡F
¡Ð¡A¹ï¥Íªø©Ê¯àµL·l®`¡F¡H¡A¤£½T©w¡C
¡@ | ¯Ø Ŧ ¤j ¤p | ¯ØŦ»Ã¯À¤Àªc |
¹«¤Î¤j¥Õ¹« ¥Ð¹«¤Î¤ÑªÇ¹« Âû°¦¤ÎÂúÃZ óγ½ ¥J½Þ Ã}¤û µU ¤HÃþ* |
¡Ï¡Ï ¡Ï¡Ï ¡Ï¡Ï n.c. n.c. n.c. n.c. ¡H |
¡Ï ¡Ï ¡Ï ¡H¡H ¡Ïor¡Ð¡H¡H ¡H¡H ¡Ï |
¡Ï¡Ï¡A¯ØŦ¤j¤p¼W¥[¡Fn.c.¡AµLÅܤơF¡H¡A¤£½T©w¡F ¡Ï¡A¯ØŦ»Ã¯À¤Àªc¼W¥[¡F¡Ð¡A¤Àªc´î¤Ö¡F??¡A¤£½T©w¡F*¡A¤j¨§¯Ø³J¥ÕúA§í¨î¦]¤l¡Cªí¤T«Y¤j¨§¤é³¹ï¯ØŦ¥H¥~¤§¨ä¥L²Õ´ªº¼vÅT¡CÁý¤©¥Í¤j¨§©Î¤j¨§¨Å²M³J¥Õ(S- oybean whey proteins)¤Þ°_¹«¤p¸z°®ª««ÅãµÛ¦a¼W¥[¡C±À¨s¨ä¦]¡A¤Dlectin¤Î¨ä¥L§ÜÀç¾i¦]¤l©Ò»¤µo¤§²ÓM¼W¥Í»P¤p¸zÖß½¤¶q¼W¥[¤§¬G(Grant et al., 1989)¡F©óÂû°¦¡BÂúÃZÁý¤©¥Í¤j¨§¤é³¤ÎÃ}¤ûµ¹¹}¸g¥[¼ö³B²z¤§¤j¨§²Ë¥ç¨ã¬Û¦P±¡§Î¡C¥Í¤j¨§¹ï¬Û¹ï¨x«¤§¼vÅT¡A¦b¹«¤è±µLÅãµÛ§ïÅÜ¡A¦ý¹ïÂúÃZ¡B½Þ°¦«h¦³ÅãµÛ¼W«¤§²{¶H¡FTemler et al. (1983)«ü¥X¡A¾¨ºÞ¦b¬Û¹ï¨x«¤è±µLÅãµÛ¼vÅT¡A¦ý¥Í¤j¨§¤§Áý¹}¡A¤w¨Ï¹«¤§¨xŦ¥NÁ¡B¨xŦ»Ã¯À¬¡©Ê»P¨xŦ¤¤polysome¤§»E¦X§@¥Î¨ü¨ì§ïÅÜ¡C¥Íªø½Þ¡BªÎ¨|½Þ(Castell¡@and Cliplef, 1988)¡B¹«(Grantet al., 1987)¦]Áý¤©°ª¶q¤j¨§©Î¤j¨§¨Å²M³J¥Õ¦Ó°§C¦Ù¦×«¶q»P¦Ù¦×²Ê³J¥Õ½è¡FÂû°¦Áý¹}¥Í¤j¨§¡A«h°§C¦Ù¼ß³J¥Õ§t¶q¡A¼W¥[°©Àf¦Ù¤¤«D³J¥Õ´á¶q(Santidrian et al., 1980)¡C ªí¤T Áý¹}¥|ºØ³J¥Õ½è¤é³10¤Ñ«á¡A¹«¦U³¡²Õ´¡B¾¹©x¤§°®ª««(§J¡þ100§J)°®Åé«
¡@ | ¥Õ³J¥Õ¹ï·Ó²Õ |
¸g¥[¼ö³B²z¤§¤j ¨§ ²Ë ²Õ | ¥Í ¤j ¨§ ²Õ | ¤j ¨§ ¨Å ²M ³J ¥Õ ²Õ |
¤p ¸z ¯Ø Ŧ ¨x Ŧ ¤ñ¥Ø³½¦Ù** ðù ¦Ù** µÌ ¸z ¦Ù** |
2.00±0.03 0.46±0.04 3.41±0.03 0.08±0.01 0.15±0.01 0.79±0.02 |
1.98±0.05 0.37±0.02* 3.41±0.03 N.D. N.D. N.D. |
2.20±0.02* 0.63±0.01* 3.48±0.04 0.08±0.01 0.14±0.01 0.76±0.02 |
2.50±0.10* 0.68±0.05* 3.56±0.08 0.08±0.01 0.12±0.01 0.70±0.01* |
* »P¹ï·Ó²Õ·¥ÅãµÛ®t²§(P¡Õ0.01)¡C **¨ú¦Û¨â«á»Lªº¦Ù¦×Á`«¡C ***¥i·»©ópH4.8¤§³J¥Õ½è¡C N.D.¥¼´ú±o¡C¥Í¤j¨§¤¤©Ò§tªº§ÜÀç¾i¦]¤l¨s³º¦³¨º¨Ç©O¡HGrant(1989)«ü¥X¡A¸g¥h¯×¤§¤j¨§²ËµÑ¨ú²G¤¤§t¦³¤T¤j³¡¥÷¡G(1)pH8®É¤§¤£·»©Ê´Ý°ò¡AY¥H²æ¯×¤j¨§²Ë¬°100®É¡A«h¬ù¦û31.5¢H¡F(2)»Ä¨I¾ý©Ê³J¥Õ½è¡A·»©ópH8¡A¦Ó¦bpH4.8¨I¾ý¡A¬ù¦û32.2¢H¡F¶i¤@¨B¥i¤ÀÂ÷¥X11S²y³J¥Õ(glycinin)¤Î7S²y³J¥Õ(conglycinin)¡F(3)¨Å²M³¡¥÷¡A·»©óp- H4.8¡A¬ù¦û5.8¢H¡A§t¦³trypsin inhibitors(Kunitz inhibitor¡A¤À¤l¶q21,000¤ÎBowm-an-Birk inhibitor¡A¤À¤l¶q¬°8,000)»Plectin¡C¦¹¥~¥t§t¦³¨Å²Mº¯ªRª«¡A¬ù¦û30¢H¡A¥iÂǥѳzªR¹Lµ{¥[¥H¥h°£¡Cglycinin¡Bconglycinin¨Ã¤£·|³y¦¨¯ØŦªº¸~¤j¡A¦ý·|»P¸z¹D¤¤peyer¡¦s patches¤§M-callsµ²¦X¤Þµo§ÜÅé¤ÏÀ³(Grant,1989)¡FSissons et al.(1982)«ü¥X¡A¤Wz¨âºØ§ÜÀç¾i¦]¤l¡A¥i§Q¥Î¼ö²G©Ê¤A¾JµÑ¨ú¤èªk(hot aqueous ethanol extra-ction)¥[¥H¥h°£¡F¦ý²G©Ê¥[¼ö³B²z(aqueous heat treatment)¨ÃµLªk¹F¨ì¦¹¤@¥Øªº¡C ªí¥| ¥h ¯× ¤j ¨§ ²Ë ¤§ ¤@ ¯ë ²Õ ¦¨
¡@ | ¶q(§J) | ´á ¶q(§J) |
²æ¯×¤j¨§²Ë pH8¤§¤£·»©Ê´Ý°ò 11S²y³J¥Õ(glycinin)* 7S²y³J¥Õ(conglycinin)* ¨Å²M³J¥Õ ¨Å²Mº¯ªRª« |
100.0 31.5 11.2 21.0 5.8 30.0 |
7.9 1.8 1.8 3.0 0.8 0.4 |
*»Ä¨I¾ý©Ê³J¥Õ½è¡C Grant¡A1989¤j¨§¨Å²M³J¥Õ¦¨¥÷(trypsin inhibitors¡Blectin)¡A¨ã°§C¯×ªÕ§l¦¬¡B¼W¥[ÁxÅnªÅ«¡A³y¦¨¤p¸z¸~¤j¤Î¦Ù¦×·l¥¢¤§t±¼vÅT(Grant, 1987)¡F¨Å²Mº¯ªRª««h§t¦³§C¤À¤l¶qªºoligopcptide©Îglycopeptide¡A·|°§C¥Íªø¡A³y¦¨¯ØŦ¸~¤j¡A¨Ã´î¤Ö¥Òª¬¸¢¹ï¸K¤§§l¦¬(Konijn et al., 1972¡Cµ¥¶qÁý¤©§t10¢H¤j¨§¨Å²M©Î¥h¥~·½¾®¶°¯À¤§¤j¨§¨Å²M³J¥Õ¡A§í©Î§t0.7¢H lectin©Î2.8¢H trypsin inhibitors(§tKunitz inhibitor¤ÎBowman-Birk in-hibitor)¡F¹ï·Ó²Õ«h¥Hlactalbumin¥[¤J§tlectin¤Îtrypsin inhibitors¤§¤é³¤¤¡C©ó16¤Ñ¤§¸ÕÅç´Áµ²ªGÅã¥Ü¡A¹ï·Ó²Õ¨ã³Ì¨Î¼W«¡A¨ä¥L¨Ì§Ç¬°¥h¥~·½¾®¶°¯À¤§¤j¨§¨Å²M³J¥Õ²Õ¡Btrypsin inhibitors²Õ¡Blectin²Õ¡A§t¤j¨§¨Å²M³J¥Õ²Õ«h¥Íªø³Ì®t¡CKakade et al. (1973)¸ÕÅç«ü¥X¡Atrypsin inhibitors·|°§C¥Íªø³t²v¬ù40¢H¡FFujita et al. (1979)¶i¤@¨B«ü¥X¦¹ºØ¸~¤jªº¹Lµ{³Ìªì«Y¯ØŦ²ÓM¤§¼W¤j¡A¦Ó«á¬°¸¢M¤Î±ÆªnºÞ²ÓM¤§¼W¤j»P¼W¥Í©ÒP¡C ¤j¨§¤¤©Ò§t¤§¥~·½¾®¶°¯À(lectin)¬°ÁÞ³J¥Õ¤§½Æ¦Xª«¡A¤À¤l¶q12,000¡F·íÁý¤©§t¥~·½¾®¶°¯À¤§¤é³«á¡A¥~·½¾®¶°¯À·|µ²¦X©ó¤p¸z°ò³¡¤§¤W¥Ö²ÓMªí±¡A¦Ó¬°¸z²ÓM©Ò§l¤J¨ì¹FªOª¬¼h¡A¦A¶i¤JÅé´`Àô¤¤¡F¨Ã³y¦¨µ³¤òÅܲʡBÅܵu¡A§õ°ö©ø¤ó¸¢ºÛ¥[²`¡A¤Þ°_Àç¾i§l¦¬¤W¤§¤£¨}¼vÅT¡C ¹«¡B¥Ð¹«¡Bª¯¡B½Þ¡BÃ}¤û¡BÂû°¦¤Î¤HÃþ¤§¯ØŦ»Ã¯À¤Àªc¬°¤@t°jõX¾÷¨î(negative feedback mechanism)¡F¯ØŦ»Ã¯À¤§¤Àªc³t²v»P¤p¸z«eºÝ¤§¯ØÁx¤Àªc(pancreaticobiliary secretions)¿@«×§e¬Û¤ÎÃö«Y(Grant et al., 1989)¡CFushiki and Iwai (1989)«ü¥X¡A¹«¤§t°jõX½Õ¸`¾÷¨î¡A¥DnÂǥѪŸz¤ºªc²ÓM¤Àªc¤§ÁYÁxÅnúV(cholecystokinin, CCK)©Ò§@¥Î¡FÁYÁxÅnúV¤§ÄÀ©ñ«h¨üªÅ¸z¤¤°ª¿@«×¤§¯Ø³J¥ÕúA¡þ¯Ø¾®¨Å³J¥ÕúA©Ò§í¨î¡CGrant (1989)¶i¤@¨B¸ÑÄÀ¡A¤é³¤¤©Ò§t¤§trypsin inhibitors«YÂÇ°§C¤p¸z¤¤¤§´åÂ÷ºA¯Ø³J¥ÕúA¤Î¯Ø¾®¨Å³J¥ÕúA¡A¤zÂZ¥¿±`¤§°jõX±±¨î¾÷¨î¡A¦]¦Ó¼W¥[ÁYÁxÅnúVÄÀ©ñúVÐ`(CCK releasing peptide)µ²¦X©óªÅ¸z¤ºªc²ÓM¤§¿@«×¡AÄÀ©ñ¥X°ª¶q¤§´`Àô©ÊÁYÁxÅnúV¡A²×¦Ó³y¦¨¯ØŦ»Ã¯À¤§¹L«×¤Àªc¡A¤Þ°_¯ØŦ¤§¼W¤j»P¼W¥Í(Fushiki and Iwai, 1989)¡C¦¹ºØ°jõX©Ê½Õ¸`¤§ºn¶Ç¾Éª«½è¦]°Êª«ºØ§O¤§¤£¦P¦Ó¦³¨ä®t²§¡ACorring et al.(1986)¡BSh- iratori et al. (1989)§Y«ü¥X¡AÁöµMÁYÁxÅnúV¹ï¹«¦Ó¨¥¬°ºn¤§¶Ç¾Éª«½è¡A¦ý¦b½Þ¡B¤ü¶È¦û¦¸n¤§¦a¦ì¡F¹ê»Ú¤W¤§ºn¶Ç¾Éª«½è¬°¤p¸z¤ºªc¯À(Secretin)¡C¡@
¤T¡B¤j¨§¹ï¹}¾i®ÄªG¤§¼vÅT
Pontif et al.(1987)¨Ï¥Î136°¦¤T«~ºØ½ü°jÂø¥æ½Þ(Hammpshires¡BYorkshires¡BDur- ocs)¡A¥§¡Åé«©ó¸ÕÅç¤@»P¸ÕÅç¤G¤À§O¬°62¤Î57¤½¤ç¤§3.5¤ëÄ֪Ψ|½Þ¡A¥H¶i¦æ¥Í¤j¨§¤§¹}¾i®ÄªG¬ã¨s¡C¥|¤é³³B²z²Õ¤À§O¥H¥Í¤j¨§¨ú¥N¤j¨§²Ë©Ò¦û²Ê³J¥Õ½è0¢H¡B33¢H¡B67¢H¡B100¢H¤§¤ñ¨Ò¡Cµ²ªGÅã¥Ü¼W«»P¹}®ÆÂà´«²vÀH¥Í¤j¨§²K¥[¤ñ²v¤§¤W¤É¦Ó§e½u©Ê¤U°(P¡Õ0.01¡Aªí¤»)¡F¤é¼W«¥çÀH¥Í¤j¨§²K¥[¶q´£°ª¦Ó°§C¡C¦Ó¦b±OÅ髤象A«h§e½u©Ê¤U°¡A«Y¨üÅé¼W«°§C©Ò¼vÅT(ªí¤C¡BPonif et al., 1987)¡CLEA(²Ä10¦Ø°©¤§¸y²´±¿n)»P¸K»ù¥çÀH¥Í¤j¨§¤§²K¥[¤ñ²v´£°ª¦Ó§e½u©Ê¼vÅT(P¡Õ0.01¡Aªí¤C)¡C§@ªÌ«ü¥X¥Í¤j¨§²K¥[¶q´£°ªP¸y²´±¿n´î¤Ö¡A¥i¯à»P¥Í¤j¨§¤¤©Ò§ttrypsin in-hibitors¡A¨Ï³J¥Õ½è¤§¥i§Q¥Î©Ê°§C¤Î¡þ©Î¥Í¤j¨§¤¤¤§§¿¯ÀúA¬¡¼â«×¦³Ãö¡AP¯Ê¥F¤@ºØ©Î¦hºØÓi°ò»Ä¡A¦X¦¨¦Ù¦×¤§¯à¤O¦]¦ÓÅÜ®t¡C§@ªÌµ²½×«ü¥X¡A¥H¥Í¤j¨§²K¥[©óªÎ¨|½Þ¤é³¤¤Áý¹}50¤Ñ¡A·|°§C¼W«¤Î¹}®ÆÂà´«²v¡A¨Ã¼vÅT¸y²´±¿n¡B°§C±OÅé«~½è¡F¬G¤£±ÀÂË©ó°l¨D³Ì¤j¼W«¡B³Ì¨Î¹}®ÆÂà´«²v»P±OÅé«~½è¤§¹}¾i¥Ø¼Ð¤W¡C³]Y°ò©ó¸gÀÙ¦Ò¶q¡A«h¥Í¤j¨§²K¥[©óªÎ¨|´Á½Þ°¦¤é³¤¤¥ç¤£À³¶W¹L13¢H¡C
ªí¤ ¹ê Åç ¤é ³ ²Õ ¦¨ (1)
ì ®Æ ²Õ ¦¨ | ¥Í ¤j ¨§ ¦Ê ¤À ¤ñ | |||
0 |
33 |
67 |
100 |
|
¥É ¦Ì
¤j ¨§ ²Ë
¥Í ¤j ¨§
ÁC »Ä ²B
¶t
¨d Ä÷ ´ß
¯»
Äqª«½è¹w©Õª« ºû¥Í¯À¹w©Õª« ¯Ø³J¥ÕúA§í¨î¦]¤l¡A²@§J¡þ§J¤é³ |
¢w¢w¢w¢w¢w¢w¢w¢w¢H¢w¢w¢w¢w¢w¢w¢w¢w |
|||
81.75 15.84 1.08 0.78 0.30 0.25 |
80.51 10.71 6.37 1.08 0.78 0.30 0.25 1.18 |
79.22 5.44 12.93 1.08 0.78 0.30 0.25 2.40 |
77.86 19.73 1.08 0.78 0.30 0.25 3.67 |
µù¡G(1)µ¥³J¥Õ½è¡Bµ¥¥NÁ¯à¤é³(C.P.14¢H¡AM.E.3200¥a¥d¡þ¤½¤ç)¡Cªí¤» ªÎ¨|½ÞÁý¹}¥Í¤j¨§¹ï¼W«»P¹}®ÆÂà´«²v¤§¼vÅT(1)¡@
¤é ³ ³B ²z ²Õ | ¼W « ¡A ¤½ ¤ç | ¹}®ÆÂà´«²v(¼W«¡þ¹}®Æ) |
°ò¦¤é³(B¡A¢H)
B¡Ï 33¢H¥Í¤j¨§ B¡Ï 66¢H¥Í¤j¨§ B¡Ï100¢H¥Í¤j¨§ Pooled SE |
0.825 0.754 0.763 0.696 0.017 |
0.276 0.278 0.268 0.253 0.004 |
µù¡G(1)¨â¸ÕÅ祧¡¸ê®Æ¡C
¡@
ªí¤C ªÎ ¨| ½Þ Áý ¹} ¥Í ¤j ¨§ ¹ï ±O Åé ©Ê ª¬ ¤§ ¼v ÅT (1)¤é ³ ³B ²z ²Õ | ±OÅé«¡A¤½¤ç |
±O®_²v¡A¢H |
¸y²´±¿n¡Acm2 | I¯×«p¡Amm | ¸K »ù |
°ò¦¤é³(B¡A¢H)
B¡Ï 33¢H¥Í¤j¨§ B¡Ï 66¢H¥Í¤j¨§ B¡Ï100¢H¥Í¤j¨§ Pooled SE |
86.1 82.6 82.9 81.2 1.05 |
80.7 80.2 80.7 80.5 0.54 |
30.0 28.5 27.7 26.0 0.61 |
33.9 32.7 34.1 34.7 0.96 |
61.6 63.4 67.1 68.9 0.69 |
µù¡G(1)¨â¸ÕÅ祧¡¸ê®Æ¡C¡@
Cook et al. (1988)¤À§O©ó¸ÕÅç¤@¡B¸ÕÅç¤G¨Ï¥Î36°¦¤Î48°¦¡A¥§¡Åé«7.0¤Î67¤½¤ç¤§Âø¥æìI¤½½Þ(Landrace¡ÑDuroc¡ÑYorkshire)¡F¸ÕÅç¤T«h¨Ï¥Î18ÀY¥§¡Åé«12.4¤½¤ç¤§Âø¥æìI¤½½Þ¡A¥H¤ñ¸ûKunitz trypsin inhibitor¹ï¥Íªø´Á¶¡»PªÎ¨|´Á½Þ°¦¥Íªø©Ê¯à¡B³J¥Õ½è¤Î¯à¶q»W¿n¤§¼vÅT¡C¤é³²Õ¦¨¦pªí¤K¡Bªí¤E©Ò¥Ü¡C
ªí¤K ¸Õ Åç ¤@ ¡B ¤G ¤§ ¤é ³ ²Õ ¦¨
¶µ ¥Ø | ¸Õ Åç ¤@ | ¸Õ Åç ¤G | ||
¤j¨§²Ë²Õ(1) | LT©ÎHT²Õ(2) |
¤j¨§²Ë²Õ |
LT©ÎHT²Õ |
|
¥É ¦Ì
¤j ¨§ ²Ë
¥Í ¤j ¨§
¥É ¦Ì ªo
ÁC »Ä ²B
¶t
¥Û ¦Ç ¥Û
¯»
Äqª«½è¹w©Õª« ºû¥Í¯À¹w©Õª« §Ü ¥Í ¯À Á` p |
64.30 26.00 7.00 1.25 0.75 0.35 0.10 0.25d 100.00 |
65.30 32.00 1.25 0.75 0.35 0.10 0.25 100.00 |
82.95 14.00 ¡@ 1.25 1.25 0.35 0.10 0.10e 100.00 |
78.91 18.00 1.25 1.25 0.35 0.10 0.10 100.00 |
¡@ | ¢w¢w¢w¢w¢w¢w¢w¢w¢w pºâÈ ¢w¢w¢w¢w¢w¢w¢w¢w¢w | |||
²Ê³J¥Õ½è¡A¢H Â÷ Ói »Ä¡A¢HÁ`¯à¡A¦Ê¸U¥d¡þ¤½¤ç Á`¯à¡A¦Ê¸U¥d¡þ¢HÂ÷Ói»Ä |
18.30 0.93 4.13 4.44 |
18.00 0.93 4.13 4.50 |
14.00 0.62 3.80 6.13 |
13.90 0.65 3.99 6.14 |
µù¡G(1)¤j¨§²Ë²Õ¡G¸g¥[¼ö¡A·»¾¯µÑ¨ú¤§¤j¨§²Ë¡C (2)LT©ÎHT²Õ¡G¨C¤½§J¥Í¤j¨§°®ª«¶q¤¤¡A§t¦³0.5²@§J(LT²Õ)¡A5²@§J(HT²Õ)¤§Kunitz trypsin inhibitor¡Cªí¤E ¸Õ Åç ¤T ¤§ ¤é ³ ²Õ ¦¨ (1)
¶µ ¥Ø | ¤j ¨§ ²Ë ²Õ | LT©ÎHT²Õ |
¤j ¨§ ²Ë
¥Í ¤j ¨§
¥É¦Ì¾ý¯» ¥É ¦Ì ªo ÅÖ ºû ¯ÀÁC»Ä²B¶t ¥Û¦Ç¥Û¯» Äqª«½è¹w©Õª« ºû¥Í¯À¹w©Õª« DL¡Ð¥Ò²¸Ói»Ä §Ü ¥Í ¯À Ethoxyguin (250ppm) Á` p p ºâ ȲʳJ¥Õ½è¡A¢H Â÷ Ói »Ä¡A¢HÁ`¯à¡A¦Ê¸U¥d¡þ¤½¤ç Á`¯à¡A¦Ê¸U¥d¡þ¢H¡AÂ÷Ói»Ä |
34.00 53.55 6.00 2.00 2.25 0.75 0.35 0.50 0.35 0.25 ¡Ï 100.00 16.20 1.02 3.90 3.82 |
48.00 45.55 2.00 2.25 0.75 0.35 0.50 0.35 0.25 ¡Ï 100.00 18.25 1.06 4.12 3.89 |
µù¡G¦pªí¤Kµù¸}¡C Cook et al., 1988¥§¡¤é³«»P¹}®ÆÂà´«²v(¼W«¡þ¹}®Æ)©ó¸ÕÅç¤@(¥Íªø´Á)¤¤¬Ò¥H§t°ª¶q¯Ø³J¥ÕúA§í¨î¦]¤l²Õ³Ì®t¡A¤À§O°§C52¢H¤Î53¢H¡A¦Ó§t§C¶q¯Ø³J¥ÕúA§í¨î¦]¤l²Õ¥ç·¥ÅãµÛ¦a°§C(P¡Õ0.01)¤é¼W«»P¹}®ÆÂà´«²v(ªí¤Q)¡F¤j¨§²Ë°ò¦¤é³²Õ«h¦³³Ì¨Î¤§¥Íªø©Ê¯à(ªí¤Q)¡C ªí¤Q Áý ¹} ¤j ¨§ ²Ë »P ¥Í ¤j ¨§ ¤§ ¥Í ªø ´Á ½Þ ½Þ ¥Í ªø ©Ê ¯à
¶µ ¥Ø | ¤j¨§²Ë²Õ |
§t§C¶q¯Ø³J¥Õ§í¨î¦]¤l²Õ |
§t°ª¶q¯Ø³J¥Õ§í¨î¦]¤l²Õ |
SE |
ªì Åé «¡A¤½¤ç
¤é ¼W «¡A¤½¤ç
¤é±Ä¹¶q¡A¤½¤ç ¹}®ÆÂà´«²v(¼W«¡þ¹}®Æ) |
6.8 0.436c 0.864 0.505c |
7.2 0.286d 0.745 0.386d |
6.8 0.211c 0.895 0.236c |
0.057 0.172 0.051 |
c¡Bd¡Beªí·¥ÅãµÛ®t²§(P¡Õ0.01)¡C©ó¸ÕÅç¤G(ªÎ¨|´Á)¤è±¡A¤é¼W«¤´¥H§t°ª¶q¯Ø³J¥ÕúA§í¨î¦]¤lªÌ³Ì®t(P¡Õ0.05)¡A¦Ó¦b¹}®ÆÂà´«²v¤W«h¥¼¹FÅãµÛ®t²§¤ô·Ç¡FÅã¥Ü¯Ø³J¥ÕúA§í¨î¦]¤l¤§¼vÅT»P¤éÄÖ¦³Ãö¡C ªí11 Áý ¹} ¤j ¨§ ²Ë »P ¥Í ¤j ¨§ ¤§ ªÎ ¨| ½Þ ¥Í ªø ©Ê ¯à¡@
¶µ ¥Ø | ¤j¨§²Ë²Õ |
§t§C¶q¯Ø³J¥Õ§í¨î¦]¤l²Õ |
§t°ª¶q¯Ø³J¥Õ§í¨î¦]¤l²Õ |
SE |
ªì Åé «¡A¤½¤ç
¥½ Åé «¡A¤½¤ç
¤é ¼W «¡A¤½¤ç
¤é±Ä¹¶q¡A¤½¤ç ¹}®ÆÂà´«²v(¼W«¡þ¹}®Æ) |
68 106 0.95c 3.27 0.291 |
67 103 0.87d 2.97 0.293 |
67 101 0.83e 3.07 0.270 |
¡@ 0.01 0.45 0.02 |
c¡Bd¡BeªíÅãµÛ®t²§(P¡Õ0.05)¡C´á¤§®ø¤Æ²v»P»W¿n²v¡A¤T³B²z²Õ¶¡¬Ò§eÅãµÛ®t²§(P¡Õ0.05)¡A©ó´á¤§®ø¤Æ²v¤W§ó¹F·¥ÅãµÛ¤ô·Ç(P¡Õ0.01)¡F¯à¶q¤§®ø¤Æ²v»P¥i¥NÁ²v©ó¹ï·Ó²Õ»P§t¯Ø³J¥ÕúA§í¨î¦]¤l¤§¨â³B²z²Õ¶¡¬Ò§eÅãµÛ®t²§(P¡Õ0.05¡Aªí¤Q¤G)¡C¤j¨§²Ë¸g¾A·í¥[¼ö¹Lµ{¡A¥i¦³®Ä¯}Ãa¯Ø³J¥ÕúA§í¨î¦]¤l(Liener and Kakade,1969)»P¤j¨§¬õ¦å²y¾®¶°¯À¡Ð¥~·½¾®¶°¯À¡F¥Ñµ²ªG¥iª¾¡A§t§C¶q¯Ø³JúA§í¨î¦]¤l(0.5²@§J¡þ§J°®ª«½è)¹ï½Þ°¦§Y¨ã§í¨î¥Íªø¡A°§C´á®ø¤Æ²v¡A»W¿n²v»P¯à¶q®ø¤Æ²v¤§t±¼vÅT¡CEndres¤]«ü¥X¡AKunitz inhibitor·|§í¨î³Ì¤j¤§³J¥Õ½è§Q¥Î¡A¦ÓBowman-Birk inhibtor¤Î¨ä¥L§í¨î¦]¤l±N¶i¤@¨B§í¨î³J¥Õ½è¤§§Q¥Î¡C¥ÑCook et al. (1988)¤§¸ÕÅçÃÒ¹ê¥Í¤j¨§¤¤©Ò§t¤§§ÜÀç¾i¦]¤l¡A½T¹ê¤£§Q©ó®a¯b¤§¥Íªø©Ê¯à¡A¤×¥H¥Íªø¶¥¬q¬°µM¡C
¡@
ªí12 ¥ ¿Å ¸Õ Åç µ² ªG ( ¸Õ Åç ¤T )
¶µ ¥Ø | ¤j¨§²Ë²Õ |
§t§C¶q¯Ø³J¥Õ§í¨î¦]¤l²Õ |
§t°ª¶q¯Ø³J¥Õ§í¨î¦]¤l²Õ |
SE |
´á Á`ÄṶq¡A§J ¥i®ø¤Æ³¡¥÷¡A¢H »W¿n²v¡A¢H ¯à¶q Á`ÄṶq¡A¦Ê¸U¥d ¥i®ø¤Æ³¡¥÷¡A¢H ¥i®ø¤Æ³¡¥÷¡A¢H |
129 91.4c 65.9f 15.9 93.9c 91.9c |
139 83.9d 59.5g 16.6 87.6d 84.6d |
136 79.1e 50.9h 16.5 85.9d 83.8d |
¡@ 1.83 2.76 ¡@ 1.56 2.54 |
c¡Bd¡BeªíÅãµÛ®t²§(P¡Õ0.05)¡C f¡Bg¡Bhªí·¥ÅãµÛ®t²§(p¡Õ0.01)¡C¥|¡Bµ² ½×
1.¥Í¤j¨§©Î¥[¼ö¤£·í¤§¤j¨§²Ë§t¦³§ÜÀç¾i¦]¤l(anti-nutritional factors)¤§¦s¦b¡A¤wª¾¬°glycinin¡Bconglycinin¡Blectin¡BKunitz inhibitor¤ÎBowman-Birk inhibitor¡C·íÁý¤©®a¯b¸V(¯S§O¬O¥Íªø¶¥¬q¤§¥J¯b)¡A·|°§C¥Íªø©Ê¯à¡A°§C´á¤§®ø¤Æ²v¤Î»W¿n²v¡F¨Ã¨Ï¤é³¤¤´á¡BºÒ¤ô¤Æ¦Xª«¡B¯×½è¤§®ø¤Æ»P§l¦¬¨ü¨ä¼vÅT¡C¹ïÂû¡BÂúÃZ¦Ó¨¥¡A¥ç·|³y¦¨¯ØŦ¸~¤j¡B¯ØŦ»Ã¯À¹L«×¤Àªc¡A¦]¦ÓµLªk¥R¤À¤À¸Ñ¤é³Àç¾i¤À¡A¾ÉP®ø¤Æ¤£¨}¡B¥ÍªøÅÜ®t¡C¾A·íªº¥[¼ö³B²z¤j¨§²Ë¡A¥i¥h°£©Ò§t¤j³¡¥÷¤§§ÜÀç¾i¦]¤l¡F±©±ý¹F§¹¥þ¤§®ÄªG¡A«h¥H¼ö²G©Ê¤A¾JµÑ¨úªk(hot aque ous-ethanol extraction)¬°³Ì¨Î¡C
2.®Ú¾Ú¬ã¨s«ü¥X¡A¥Í¤j¨§²K¥[©óªÎ¨|½Þ°¦¤é³¤¤¡AÅãµÛ°§C¥Íªø©Ê¯à»P±OÅé«~½è¡F±©Y°ò©ó¸gÀÙ¦Ò¶q¡A«h²K¥[¶q¤£¥i¶W¹L13¢H¡C¦¹¥~Cook et al. (1988)¥çÃÒ¹ê¡A§Y¨Ï«D±`§C¶q(0.5²@§J¡þ§J°®ª«½è)¤§Kunitz trypsin inhibitor¡A¥i¹ï¥Íªø½Þ¤ÎªÎ¨|½Þ³y¦¨ÅãµÛ¤§¥Íªø©Ê¯à¡A´á¤Î¯à¶q®ø¤Æ²v»P»W¿n²v¤§°§C¡A¤×¥H¥Íªø´Á¬°µM¡C¬O¥H¹}®Æì®Æ¤§²Õ¦¨¯S©Ê¡A¹}®Æì®Æ©¼¦¹¶¡¤§§@¥ÎÃö«Y¡A¥H¤Îì®Æ¤¤©Ò§t¬rª«¦]¤l©Î§ÜÀç¾i¦]¤l¡A¬Ò¶·©ó¤é³½Õ°t®É¼f·V³B²z¡C
¡@
¹}®ÆÀç¾iÂø»x(3~16)
92¦~¡D²Ä¤G´Á¢w¤ý³Ó¼w
Copyright © 1998 Z¸s®n¯bªªºô.
¥»ºô¯¸¹Ï¤å«YÄÝZ¸s®n¦³¤½¥q¡A¤º¤å¤§ª©Åv¬°¸ÓÂø»xªÀ©Ò
¦³¡A«D¸g¥»¤½¥q¤Î¸ÓÂø»xªÀ¥¿¦¡®Ñ±¦P·N¡A¤£±o±N¥þ³¡©Î³¡¤À¤º®e¡A
Âà¸ü©ó¥ô¦ó§Î¦¡´CÅé
¡° ³Ì¨Î¸ÑªR«× 800x600
Copyright © 1998
MiobufferCo., Ltd. All rights reserved.
Unauthorized copying and reproduction is prohibited. All trademarks property of their
respective holders.